HK1024932A1 - Mammalian cytokine: interleukin-b30 and related reagents - Google Patents

Mammalian cytokine: interleukin-b30 and related reagents

Info

Publication number
HK1024932A1
HK1024932A1 HK00103140.3A HK00103140A HK1024932A1 HK 1024932 A1 HK1024932 A1 HK 1024932A1 HK 00103140 A HK00103140 A HK 00103140A HK 1024932 A1 HK1024932 A1 HK 1024932A1
Authority
HK
Hong Kong
Prior art keywords
interleukin
related reagents
mammalian cytokine
cytokine
mammalian
Prior art date
Application number
HK00103140.3A
Other languages
English (en)
Inventor
J Fernando Bazan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25413278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1024932(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1024932A1 publication Critical patent/HK1024932A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK00103140.3A 1997-07-25 2000-05-26 Mammalian cytokine: interleukin-b30 and related reagents HK1024932A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90090597A 1997-07-25 1997-07-25
PCT/US1998/015423 WO1999005280A1 (en) 1997-07-25 1998-07-24 Mammalian cytokine: interleukin-b30 and related reagents

Publications (1)

Publication Number Publication Date
HK1024932A1 true HK1024932A1 (en) 2000-10-27

Family

ID=25413278

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00103140.3A HK1024932A1 (en) 1997-07-25 2000-05-26 Mammalian cytokine: interleukin-b30 and related reagents

Country Status (29)

Country Link
EP (3) EP1002084B1 (hu)
JP (5) JP4316133B2 (hu)
KR (1) KR100666835B1 (hu)
CN (2) CN101851286A (hu)
AR (2) AR017510A1 (hu)
AT (1) ATE443142T1 (hu)
AU (1) AU741046B2 (hu)
BR (1) BR9811039A (hu)
CA (1) CA2296272C (hu)
CO (1) CO4810232A1 (hu)
CZ (1) CZ300958B6 (hu)
DE (1) DE69841161D1 (hu)
DK (2) DK2100959T3 (hu)
ES (2) ES2331762T3 (hu)
HK (1) HK1024932A1 (hu)
HU (1) HU230629B1 (hu)
ID (1) ID28114A (hu)
IL (3) IL134068A0 (hu)
LT (1) LT2100959T (hu)
MY (1) MY157028A (hu)
NO (1) NO329329B1 (hu)
NZ (1) NZ502391A (hu)
PE (1) PE20000183A1 (hu)
PL (1) PL197150B1 (hu)
PT (2) PT1002084E (hu)
SK (1) SK287198B6 (hu)
TW (1) TWI237057B (hu)
WO (1) WO1999005280A1 (hu)
ZA (1) ZA986596B (hu)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
EP1033373B1 (en) * 1997-10-23 2006-06-14 Nippon Institute for Biological Science Feline granulocyte colony-stimulating factor
AU2661199A (en) * 1998-02-06 1999-08-23 Schering Corporation Mammalian receptor proteins; related reagents and methods
DE69942607D1 (de) * 1998-04-14 2010-09-02 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein
EP3184637A1 (en) 1999-09-09 2017-06-28 Merck Sharp & Dohme Corp. Mammalian interleukin-12 p40 and interleukin b30 complexes, antibodies, uses in pharmaceutical compositions
HU230679B1 (en) * 1999-09-09 2017-08-28 Merck Sharp & Dohme Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions
US7090847B1 (en) 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
AU2005202420B2 (en) * 1999-09-09 2008-08-07 Merck Sharp & Dohme Corp. Mammalian cytokines; related reagents and methods
DE60328823D1 (de) 2002-10-30 2009-09-24 Genentech Inc Hemmung von il-17 produktion
EP1623011B1 (en) 2003-05-09 2013-01-02 Janssen Biotech, Inc. Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
WO2005108425A1 (en) * 2004-05-10 2005-11-17 Cytos Biotechnology Ag Il-23 p19 antigen array and uses thereof
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
PT2452694T (pt) 2005-06-30 2019-02-21 Janssen Biotech Inc Anticorpos anti-il-23, composições, métodos e utilizações
KR101210395B1 (ko) 2005-12-29 2012-12-11 얀센 바이오테크 인코포레이티드 인간 항-ｉｌ-23 항체, 조성물, 방법 및 용도
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
WO2007147019A2 (en) 2006-06-13 2007-12-21 Zymogenetics, Inc. Il-17 and il-23 antagonists and methods of using the same
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
AU2008328779B2 (en) 2007-11-27 2014-06-05 Ablynx N.V. Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
CA2721713C (en) 2008-05-05 2019-07-09 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
MX2011011729A (es) 2009-05-05 2012-04-10 Novimmune Sa Anticuerpo anti il-17f y metodos de uso de los mismos.
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
EP3456740A1 (en) 2010-11-04 2019-03-20 Boehringer Ingelheim International GmbH Anti-il-23 antibodies
EA201401204A1 (ru) 2012-05-03 2015-05-29 Бёрингер Ингельхайм Интернациональ Гмбх Антитела к il-23p19
CA2906384A1 (en) 2013-03-15 2014-09-18 Amgen Inc. Methods for treating crohn's disease using an anti-il23 antibody
SG11201507482UA (en) 2013-03-15 2015-10-29 Amgen Inc Methods for treating psoriasis using an anti-il-23 antibody
EP3708679A1 (en) 2014-07-24 2020-09-16 Boehringer Ingelheim International GmbH Biomarkers useful in the treatment of il-23a related diseases
KR102523914B1 (ko) 2014-09-03 2023-04-19 베링거잉겔하임인터내쇼날유한회사 Il-23a 및 tnf-알파를 표적으로 하는 화합물 및 이의 용도
CN108290058B (zh) 2015-09-17 2023-05-16 美国安进公司 使用il23途径生物标志物预测il23拮抗剂的临床应答
JP2019508370A (ja) 2015-12-22 2019-03-28 アムジェン インコーポレイテッド Ｉｌ２３アンタゴニストに対する臨床応答の予測因子としてのｃｃｌ２０
CA3105598A1 (en) 2018-07-13 2020-01-16 Carl GOMMOLL Treating ulcerative colitis with brazikumab
MA55149A (fr) 2018-11-20 2021-09-29 Janssen Biotech Inc Procédé sûr et efficace de traitement du psoriasis avec un anticorps spécifique anti-il-23
CA3138241A1 (en) 2019-05-23 2020-11-26 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
JP2023509373A (ja) 2019-12-20 2023-03-08 ノヴァロック バイオセラピューティクス， リミテッド 抗インターロイキン－２３ ｐ１９抗体およびそれの使用方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2031216A1 (de) 1969-06-19 1971-01-14 Citizen Watch Co Ltd , Tokio Tag und Datum Stellvorrichtung fur Uhren mit Kalender
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
EP0088994B1 (en) 1982-03-15 1991-06-19 Schering Corporation Hybrid dna, binding composition prepared thereby and processes therefor
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
DE69942607D1 (de) * 1998-04-14 2010-09-02 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein

Also Published As

Publication number Publication date
CN1271387A (zh) 2000-10-25
JP2013034480A (ja) 2013-02-21
CA2296272C (en) 2012-03-13
ZA986596B (en) 1999-02-08
HUP0004019A3 (en) 2003-08-28
PL338262A1 (en) 2000-10-09
LT2100959T (lt) 2017-01-10
JP2010011863A (ja) 2010-01-21
IL134068A0 (en) 2001-04-30
JP4316133B2 (ja) 2009-08-19
JP2001511347A (ja) 2001-08-14
DK1002084T3 (da) 2010-01-04
ID28114A (id) 2001-05-03
SK912000A3 (en) 2000-09-12
DE69841161D1 (de) 2009-10-29
WO1999005280A1 (en) 1999-02-04
EP2100959A2 (en) 2009-09-16
CA2296272A1 (en) 1999-02-04
EP2100959B1 (en) 2016-12-07
NO20000343D0 (no) 2000-01-24
PE20000183A1 (es) 2000-03-11
IL134068A (en) 2010-11-30
HU230629B1 (hu) 2017-04-28
AR017510A1 (es) 2001-09-12
NO20000343L (no) 2000-03-24
HUP0004019A2 (en) 2001-03-28
PT1002084E (pt) 2009-12-16
IL205765A0 (en) 2011-07-31
KR100666835B1 (ko) 2007-01-11
ES2610483T3 (es) 2017-04-27
IL205765A (en) 2015-07-30
AU8589498A (en) 1999-02-16
CZ2000263A3 (cs) 2000-06-14
PL197150B1 (pl) 2008-03-31
ATE443142T1 (de) 2009-10-15
AR086483A2 (es) 2013-12-18
EP1002084A1 (en) 2000-05-24
TWI237057B (en) 2005-08-01
AU741046B2 (en) 2001-11-22
KR20010022214A (ko) 2001-03-15
NO329329B1 (no) 2010-09-27
MY157028A (en) 2016-04-15
BR9811039A (pt) 2000-08-08
CN101851286A (zh) 2010-10-06
DK2100959T3 (en) 2017-01-30
JP2015037405A (ja) 2015-02-26
CO4810232A1 (es) 1999-06-30
EP2100959A3 (en) 2009-10-14
EP1002084B1 (en) 2009-09-16
EP2233574A1 (en) 2010-09-29
ES2331762T3 (es) 2010-01-14
SK287198B6 (sk) 2010-03-08
CZ300958B6 (cs) 2009-09-23
JP2005323610A (ja) 2005-11-24
NZ502391A (en) 2002-12-20
PT2100959T (pt) 2017-01-09

Similar Documents

Publication Publication Date Title
HUP0004019A3 (en) Mammalian cytokine: interleukin-b30 and related reagents
AU7103198A (en) Mammalian cytokines; related reagents and methods
IL148300A0 (en) Mammalian cytokines; related reagents and methods
HUP0100436A3 (en) Mammalian cytokine-like polypeptide-10
GB9720148D0 (en) Gene silencing materials and methods
AU6700598A (en) Intron-mediated recombinant techniques and reagents
EP1005479A4 (en) RNS INSULATION REAGENT AND METHOD
GB9705903D0 (en) VP22 Proteins and uses thereof
GB9727172D0 (en) Reagents specific for st2l and uses therefor
IL133582A0 (en) Mammalian neuro-growth factor like protein
IL126923A0 (en) Mammalian tolloid-like gene and protein
GB9701710D0 (en) Mammalian protein
IL136988A0 (en) Novel nucleic acid and polypeptide
GB9713666D0 (en) Biosensor materials and methods
GB9704162D0 (en) Assay methods and means
GB9417793D0 (en) Bioluminescence and assay reagents
EP0998578A4 (en) SEL-10 AND USES OF SEL-10
AU1664299A (en) Autodegradable microcarriers and their use
PL341293A1 (en) Beta-lypothropin and application thereof
AU9786498A (en) Human receptor proteins; related reagents and methods
AU7959598A (en) Mammalian melanocortin receptors and uses
IL136693A0 (en) V196 dna and polypeptides
AU6258399A (en) Intron-mediated recombinant techniques and reagents
GB0120368D0 (en) Assays therapeutic methods and means
AU6762398A (en) Mammalian cytokine receptor

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160724